Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

785.41 +18.81 (+2.45%)
Official Closing Price Updated: 7:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,170,628
Open 761.95
Bid (Size) 780.00 (1)
Ask (Size) 785.15 (3)
Prev. Close 766.60
Today's Range 760.49 - 789.29
52wk Range 624.68 - 972.53
Shares Outstanding N/A
Dividend Yield 0.66%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
Via The Motley Fool
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention. 
Via The Motley Fool

Performance

YTD
+0.94%
+0.94%
1 Month
-1.10%
-1.10%
3 Month
-12.02%
-12.02%
6 Month
-2.39%
-2.39%
1 Year
+25.14%
+25.14%

More News

Read More
Prediction: 3 Stocks That'll Be Worth More Than Berkshire Hathaway 5 Years From Now
Via The Motley Fool
Why Eli Lilly Stock Topped the Market Today
Via The Motley Fool
Friday's session: top gainers and losers in the S&P500 index
Via Chartmill
Is Novo Nordisk Stock a Buy?
Via The Motley Fool
Why Novo Nordisk Stock Jumped a Lucky 7.7% Today
Via The Motley Fool
Allurion Catapults 200% On Its Plans To Outdo Eli Lilly, Novo Nordisk
Via Investor's Business Daily
3 Richly Valued Stocks I'll Be Watching Like a Hawk in 2025
Via The Motley Fool
Novo Nordisk Stock Eyes Best Day In 17 Months On New Obesity Drug Trial Data: Retail Breathes Easy
Via Stocktwits
Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results
Via Investor's Business Daily
2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher
Via The Motley Fool
Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is the Stock in Trouble?
Via The Motley Fool
Topics Earnings
Exposures Financial
My Top 5 Stocks to Buy in Early 2025
Via The Motley Fool
5 Stocks On Sale: Values Or Traps?
Via Talk Markets
Topics Stocks / Equities
Maxwell Biosciences Announces Appointment of José Antonio Alas to Its Board of Directors
Via Newsfile
Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
Via MarketBeat
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
Via Benzinga
Stock Of The Day: Lilly's Strong Support Level Signals Potential Rebound
Via Benzinga
Healthcare And Biotech Stocks Lag The Market Again
Via Talk Markets
Topics Stocks / Equities
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Via Benzinga
Should You Buy the Dip in Eli Lilly Stock Right Now?
Via The Motley Fool
Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
Via The Motley Fool
3 Unstoppable Stocks to Buy in 2025
Via The Motley Fool
Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity?
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.